It would seem that these somewhat archaic downers have been mostly relegated to the dustbin of history. Indeed, pill-popping lore, which has elevated the likes of methaqualone to near mythical status (and for good reason), seems to have largely bypassed these worthy intoxicants. The shit-drug phenobarbital notwithstanding, barbs, especially the rapid-acting variety, send the user into a drunken, ataxic state of oblivion (so I am told). Nothing particularly awe-inspiring or "spiritually enlightening", but getting fucked-up does have its merits.
Structure-activity relationships for barbiturates are fairly straightforward. The general rules are as follows:
1.) Potency is directly proportional to hydrophobicity and the size and bulkiness of the 5,5 substituents, and inversely proportional to duration of action.
2.) Branching in the alkyl substituents increases potency.
3.) Unsaturation in the alkyl substituents increases potency.
4.) In general, asymmetrical substituents increase potency more than symmetrical substituents.
5.) Substituents that are branched at the carbon adjacent to the barbituric acid ring increase potency more than substituents in which the branching occurs elsewhere.
Thus, 5,5-diethylbarbituric acid, ie barbital (http://en.wikipedia.org/wiki/Barbital), is among the weakest and longest-lasting of the common barbiturates, amobarbital (http://en.wikipedia.org/wiki/Amobarbital) is more potent and rapid-acting than barbital, pentobarbital (http://en.wikipedia.org/wiki/Pentobarbital) is more potent than amobarbital, and secobarbital (http://en.wikipedia.org/wiki/Secobarbital) is more potent than pentobarbital.
As for achievable modes of synthesis, the hardest part seems to be attaching the alkyl substituents, which is usually accomplished by alkylation of diethyl malonate with the appropriate alkyl bromides in the presence of sodium alkoxides. This is followed by condensation and cyclization with urea, again in the presence of an alkoxide.
However, it seems a shortcut has presented itself in the way of certain branched-chain amino acids such as leucine and isoleucine. By nitrosation in the presence of HCl, these amino acids can be transformed into alpha-chloro acids, which can be reacted with aqueous cyanide salts and hydrolyzed to arrive at a substituted malonic acid (in the cases of leucine and isoleucine, isobutyl and sec-butyl substitution, respectively) without the need for alkylation (http://www.orgsyn.org/orgsyn/prep.asp?prep=cv8p0119). Of course, a second alkylation, which can be achieved with readily available ethyl or isopropyl bromide, is in order. Most facile is alkylation with the reactive allyl bromide, which proceeds even in aqueous NaOH, and leads to a potent end product.
Combined with the OTC generation of Na alkoxides by azeotropic distillation of NaOH in a solution of alcohol and toluene or xylene, the result is a pretty straightforward synthesis for those skilled in the art.
Structure-activity relationships for barbiturates are fairly straightforward. The general rules are as follows:
1.) Potency is directly proportional to hydrophobicity and the size and bulkiness of the 5,5 substituents, and inversely proportional to duration of action.
2.) Branching in the alkyl substituents increases potency.
3.) Unsaturation in the alkyl substituents increases potency.
4.) In general, asymmetrical substituents increase potency more than symmetrical substituents.
5.) Substituents that are branched at the carbon adjacent to the barbituric acid ring increase potency more than substituents in which the branching occurs elsewhere.
Thus, 5,5-diethylbarbituric acid, ie barbital (http://en.wikipedia.org/wiki/Barbital), is among the weakest and longest-lasting of the common barbiturates, amobarbital (http://en.wikipedia.org/wiki/Amobarbital) is more potent and rapid-acting than barbital, pentobarbital (http://en.wikipedia.org/wiki/Pentobarbital) is more potent than amobarbital, and secobarbital (http://en.wikipedia.org/wiki/Secobarbital) is more potent than pentobarbital.
As for achievable modes of synthesis, the hardest part seems to be attaching the alkyl substituents, which is usually accomplished by alkylation of diethyl malonate with the appropriate alkyl bromides in the presence of sodium alkoxides. This is followed by condensation and cyclization with urea, again in the presence of an alkoxide.
However, it seems a shortcut has presented itself in the way of certain branched-chain amino acids such as leucine and isoleucine. By nitrosation in the presence of HCl, these amino acids can be transformed into alpha-chloro acids, which can be reacted with aqueous cyanide salts and hydrolyzed to arrive at a substituted malonic acid (in the cases of leucine and isoleucine, isobutyl and sec-butyl substitution, respectively) without the need for alkylation (http://www.orgsyn.org/orgsyn/prep.asp?prep=cv8p0119). Of course, a second alkylation, which can be achieved with readily available ethyl or isopropyl bromide, is in order. Most facile is alkylation with the reactive allyl bromide, which proceeds even in aqueous NaOH, and leads to a potent end product.
Combined with the OTC generation of Na alkoxides by azeotropic distillation of NaOH in a solution of alcohol and toluene or xylene, the result is a pretty straightforward synthesis for those skilled in the art.